Michael H Kanter
Overview
Explore the profile of Michael H Kanter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kanter M, Schottinger J, Joshua A, Slezak J
Jt Comm J Qual Patient Saf
. 2022 Jul;
48(8):388-394.
PMID: 35902142
Background: Colon cancer, a potentially preventable and curable cancer, remains one of the leading causes of cancer-related death in the United States. In 2010 the researchers undertook a multifaceted initiative...
12.
Kim J, Rodriguez H, Holmboe E, McDonald K, Mazotti L, Rittenhouse D, et al.
J Grad Med Educ
. 2022 Jun;
14(3):281-288.
PMID: 35754636
Background: Graduate medical education (GME) program leaders struggle to incorporate quality measures in the ambulatory care setting, leading to knowledge gaps on how to provide feedback to residents and programs....
13.
14.
Langer-Gould A, Cheng S, Li B, Smith J, Kanter M
Ann Neurol
. 2022 Mar;
92(2):164-172.
PMID: 35285095
Objective: This study was undertaken to evaluate a multicomponent health system intervention designed to reduce escalating disease-modifying treatment (DMT) expenditures and improve multiple sclerosis (MS) outcomes by increasing use of...
15.
16.
Fischer H, Hahn E, Li B, Munoz-Plaza C, Luong T, Harrison T, et al.
Jt Comm J Qual Patient Saf
. 2022 Feb;
48(4):222-232.
PMID: 35190249
Background: High-risk medication dispenses to patients with a prior fall or hip fracture represent a potentially dangerous disease-drug interaction among older adults. The research team quantified the prevalence, identified risk...
17.
Lurvey L, Kanter M
Jt Comm J Qual Patient Saf
. 2022 Jan;
48(2):69-70.
PMID: 35090583
No abstract available.
18.
Harrison T, Reynolds K, Hahn E, Munoz-Plaza C, Yi D, Fischer H, et al.
J Manag Care Spec Pharm
. 2021 Dec;
28(1):16-25.
PMID: 34949121
Therapy with angiotensinconverting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) requires laboratory monitoring to avoid hyperkalemia and acute kidney failure. To assess the frequency of recommended annual serum potassium...
19.
Langer-Gould A, Cheng S, Li B, Kanter M
Ann Clin Transl Neurol
. 2021 Oct;
8(11):2146-2154.
PMID: 34662494
Objective: To design and implement a health system level intervention to reduce escalating multiple sclerosis (MS) disease modifying treatment (DMT) expenditures and improve outcomes. Methods: We conducted stakeholder meetings, reviewed...
20.
Glass D, Wang S, Minardi P, Kanter M
JAMA Netw Open
. 2021 Apr;
4(4):e213053.
PMID: 33822069
Importance: There is widespread consensus on the challenges to meeting the end-of-life wishes of decedents in the US. However, there is broad but not always recognized success in meeting wishes...